Randox has developed a test for COVID-19 (SARS-CoV-2), the new strain of coronavirus. The only test in the world that can identify the lethal strain and differentiate between other non-lethal variants with the same symptoms. With a global aging population and the increase of inter-linked conditions it is vital to perform comprehensive testing. With the new coronavirus panel available from Randox this will aid the screening and isolation of individuals that require quarantine and immediate intervention, determining positive samples and therefore allowing quick decision making. Six strains of coronavirus including SARS-CoV-2 (SARS-CoV-2, 229E, NL63, OC43, HKUI and MERS- CoV) are detected on this panel. The wider panel provides a more comprehensive respiratory screen enabling informed treatment decisions to be made. The Randox testing method for COVID-19 is a molecular assay based on the detection of the nucleic material (RNA) within the virus. Whereas other testing methods are based on the detection of antibodies which are only produced as a response to the infection, detection of viral RNA allows for the identification of an infection at a much earlier stage since initial exposure. CORONAVIRUS TEST AVAILABLE AT RANDOX VIRUS SARS-CoV-2 (COVID-19) Adenovirus A/B/C/D/E Sarbecovirus (SARS, SARS like, SARS-CoV-2) Enterovirus A/B/C Coronavirus 229E/NL63 Influenza A Coronavirus OC43/HKUI Influenza B Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Rhinovirus A/B